Experts believe a wider spat with Europe would be much more damaging than the current tit-for-tat with China.Traderead more
After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
Markets pay particular attention to Italy's spending, given its public debt pile. This stands at above 130% of its growth rate, one of the highest in the world.Politicsread more
Flight bookings to Hong Kong have fallen 10%, hit by the unrest in the city, said Alan Joyce, the chief executive of Australian carrier Qantas Airways.Airlinesread more
Analysts generally doubt how effective the People Bank of China's latest interest rate announcement will be in significantly helping businesses grow.China Economyread more
These in-demand skills can command top pay packets, says Feon Ang of professional networking site LinkedIn.Get Aheadread more
Japanese manufacturing activity shrank for a fourth straight month in August as export orders fell at a sharper pace.Asia Marketsread more
The Washington governor had centered his campaign around climate change, calling it "the most urgent challenge of our time."Politicsread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
Medical device maker Medtronic posted a better-than-expected quarterly profit on Thursday, boosted by higher sales at its unit that makes surgical instruments used to treat hernia and kidney ailments.
The company has been building its minimally invasive and robotic surgery device business through acquisitions to ease the impact of rising competition it faces at its top-earning cardiac and vascular unit that makes stents and heart pumps.
The minimally invasive therapies business brought in revenue of $2.26 billion in the fourth quarter, above estimates of $2.23 billion, according to IBES data from Refinitiv.
The company's biggest unit, which makes defibrillators, pace-makers, heart valves and stents, earned revenue of $3.05 billion. Analysts were expecting $3.08 billion from the cardiac and vascular business.
Medtronic expects full-year adjusted earnings between $5.44 and $5.50 per share. Analysts had forecast a profit of $5.44.
Net income attributable to the company fell to $1.17 billion, or 87 cents per share, in the fourth quarter ended April 26, from $1.46 billion, or $1.07 per share, a year earlier.
Excluding items, Medtronic earned $1.54 per share, beating analysts' expectations of $1.46 a share.
Shares of the Dublin-based company rose about 1% to $89.70 in premarket trading.